Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current approach to cancer treatment. Although the use of ICIs has become the standard of care for advanced melanoma, reports of ICI use among Asian populations with melanoma are limited. Therefore, we conducted this retr...

Полное описание

Библиографические подробности

Главные авторы:	Chiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, Pei-Wei Huang, Yu-Fen Lin, Chi-Yuan Cheng, Yao-Yu Chang, Huan-Wu Chen, Jia-Juan Hsieh, John Wen-Cheng Chang
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2020-06-01
Серии:	Frontiers in Oncology
Предметы:	melanoma immunotherapy nivolumab ipilimumab pembrolizumab immune checkpoint inhibitors
Online-ссылка:	https://www.frontiersin.org/article/10.3389/fonc.2020.00905/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!